跳至主要内容
临床试验/EUCTR2007-005090-65-IT
EUCTR2007-005090-65-IT进行中(未招募)不适用

ew therapeutic approaches in the treatment of anaplastic thyroid cancer: a phase II trial of valproic acid and paclitaxel in solid tumours - ND

AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO0 个研究点开始时间: 2007年12月11日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1.Patients with anaplastic thyroid cancer or with metaststic solid tumours, treated with paclitaxel
  • 2.Age> 18 years
  • 3.Performance status ≤ 2 (ECOG).
  • 4.Availability to give a written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1.Hepatic (bilirubin > 2mg/dl; ALT > 3 times the upper limit of normality) and/or renal (creatinine > 2mg/dl) failure
  • 2.Thrombocytopenia and/or thrombocytopathy
  • 3.Treatment with aspirin or antiplatelet agents
  • 4.Treatment with antipsychotic drugs
  • 5.Impossibility to get an informed consent due to impaired consciousness
  • 6.Pregnant or breastfeeding women
  • 7.Fertile women not taking contraceptive pills

研究者

发起方
AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO

相似试验